Single-Quantum Dot Tracking Reveals Altered Membrane Dynamics of an Attention Deficit/Hyperactivity Disorder-Derived Dopamine Transporter Coding Variant.

Related Articles

Single-Quantum Dot Tracking Reveals Altered Membrane Dynamics of an Attention Deficit/Hyperactivity Disorder-Derived Dopamine Transporter Coding Variant.

ACS Chem Neurosci. 2015 Mar 8;

Authors: Kovtun O, Sakrikar D, Tomlinson ID, Chang JC, Arzeta-Ferrer X, Blakely RD, Rosenthal SJ

Abstract
The presynaptic, cocaine- and amphetamine-sensitive dopamine (DA) transporter (DAT, SLC6A3) controls the intensity and duration of synaptic dopamine signals by rapid clearance of the neurotransmitter back into presynaptic nerve terminals. Abnormalities in DAT-mediated dopamine clearance have been linked to a variety of neuropsychiatric disorders, including addiction and attention deficit/hyperactivity disorder (ADHD). Membrane trafficking of DAT appears to be an important, albeit poorly understood, post-translational regulatory mechanism, although its dysregulation has been recently proposed as a potential risk determinant of these disorders. Unfortunately, the physical link between DAT dysregulation and changes in DAT cell surface dynamics has yet to be inspected due to the poor spatiotemporal resolution of conventional biochemical and optical techniques. Here, we utilize high-affinity, DAT-specific antagonist-conjugated quantum dot (QD) probes to establish the dynamic mobility of wild-type and mutant DATs at the plasma membrane of living Flp-In 293 cells. Single DAT-QD complex trajectory analysis revealed that the ADHD-associated DAT R615C variant exhibited increased membrane mobility relative to wild-type DAT, with diffusion rates comparable to that achieved after lipid raft disruption. This phenomenon was accompanied by a loss of transporter mobilization triggered by amphetamine, a component of widely prescribed ADHD medications. Together, our data provide the first dynamic imaging of DAT molecules, shedding new insights into the surface trafficking of both wild-type and disease-associated transporters. Our approach should be generalizable to future studies that explore the possibilities of perturbed surface DAT dynamics that may arise as a consequence of genetic alterations, regulatory changes, and drug use that contribute to the etiology or treatment of neuropsychiatric disorders.

PMID: 25747272 [PubMed – as supplied by publisher]

via http://ift.tt/1KSr2TU